Stage

Acquired

Total Raised

$237M

Investors Count

2

Portfolio Exits

1

Investments

1

Funding, Valuation & Revenue

2 Fundings

R-Pharm has raised $237M over 2 rounds.

R-Pharm's latest funding round was a Debt for $237M on October 13, 2015.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/13/2015

Debt

$237M

$XXM

0

FY undefined

1

Other Investors

$XXM

0

FY undefined

0

Date

10/13/2015

Round

Debt

Other Investors

Amount

$237M

Investors

Valuation

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

Sources

1

0

Start free trial
New call-to-action

R-Pharm Investors

2 Investors

R-Pharm has 2 investors. Vnesheconombank invested in R-Pharm's Debt funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/13/2015

10/13/2015

1
Debt

Bank

Russian Federation

OrbiMed

Subscribe to see more

Venture Capital

New York

First funding

10/13/2015

Last Funding

10/13/2015

Investor

OrbiMed

Rounds

1
Debt

Subscribe to see more

Board Seats

Type

Bank

Venture Capital

Location

Russian Federation

New York

R-Pharm Investments

1 Investments

R-Pharm has made 1 investments. Their latest investment was in eApteka as part of their Corporate Minority on October 26, 2020.

CBI Logo

R-Pharm Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/26/2020

Corporate Minority

eApteka

Yes

1

Date

10/26/2020

Round

Corporate Minority

Company

eApteka

Amount

New?

Yes

Co-Investors

Sources

1

R-Pharm Portfolio Exits

1 Portfolio Exit

R-Pharm has 1 portfolio exit. Their latest portfolio exit was eApteka on September 22, 2025.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/22/2025

Acquired

$XXM

Acquirer

4

Date

9/22/2025

Exit

Acquired

Companies

Valuation

$XXM

Acquirer

Acquirer

Sources

4

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.